Abstract
Background and objective
Klinefelter Syndrome (KS) is the most common sex chromosome aneuploidy (47, XXY) and cause of male hypergonadotropic hypogonadism. It is characterized by an extreme clinical heterogeneity in presentation, including infertility, hypogonadism, language delay, metabolic comorbidities, and neurocognitive and psychiatric disorders. Since testosterone is known to have organizational, neurotrophic and neuroprotective effects on brain, the condition of primary hypogonadism could play a role. Moreover, given that KS subjects have an additional X, genes on the extra-chromosome could also exert a significant impact. The aim of this narrative review is to analyze the available literature on the relationship between KS and neuropsychiatric disorders.
Methods
To extend to the best of published literature on the topic, appropriate keywords and MeSH terms were identified and searched in Pubmed. Finally, references of original articles and reviews were examined.
Results
Both morphological and functional studies focusing on the brain showed that there were important differences in brain structure of KS subjects. Different psychiatric disorders such as Schizophrenia, autism, attention deficit hyperactivity disorder, depression and anxiety were frequently reported in KS patients according to a broad spectrum of phenotypes. T supplementation (TRT) was not able to improve the psychotic disorders in KS men with or without overt hypogonadism.
Conclusion
Although the risk of psychosis, depression and autism is increased in subjects with KS, no definitive evidence has been found in studies aiming at identifying the relationship between aneuploidy, T deficit and the risk of psychiatric and cognitive disorders in subjects affected by KS.
Keywords: Klinefelter Syndrome, Hypergonadotropic hypogonadism, testosterone, autism, schizophrenia, attention deficit, hyperactivity disorder, depression; anxiety
1. INTRODUCTION
Sex differences, their characterization in psychosis and their interaction with laterality are placed within the context of the XY gene hypothesis [1]. Besides differences in clinical manifestations, age of onset and response to therapy, there is a sex-specific cerebral anatomical asymmetry known as “cerebral torque”: this is represented by a bias (diagonal) from the right frontal to the left occipital owing to the lateralization of functions, in particular, the language. This asymmetry is more evident in males, whereas the brain seems to develop faster in females [2, 3]. Human “experiments of nature” are useful in analyzing the potential impact of anomalous sex-chromosome gene expression on cerebral dimorphism; among aneuploidies, Turner syndrome (45,X) and Klinefelter syndrome (47,XXY) (KS) are classified. KS provides the opportunity to study the possible role of the extra X chromosome on psychosis development.
On the long arm of X chromosome (Xq11.2-12), the androgen receptor (AR) is mapped. Several studies suggested a relationship between the polymorphism in the number of CAG repeats on exon-1 at the N-terminal domain and clinical signs (including height, arms span, body) composition and bone mineral density), as well as social behavior or preference for specific jobs [4, 5]. Testosterone (T) is known to have an organizational, neurotrophic and neuroprotective effect on the brain; since KS subjects may often show low levels of T, it can be hypothesized that hypogonadism could play a role in the characterization of neurocognitive functions and in psychiatric morbidity [6].
This review aims to sum up the latest and advanced researches on the relationship between aneuploidy, hypogonadism and neurological and neuropsychiatric disorders in KS.
2. METHODs for narrative review of literature
To extend to the best of the published literature on the topic, a three-step search strategy was planned. First, we identified keywords and MeSH terms in Pubmed. Secondly, the terms above were searched in Pubmed. Thirdly, references of included original articles and reviews were searched for additional papers. The last search was performed on December 2017.
3. Klinefelter syndrome: clinical features and general aspects
KS is the most common sex chromosome aneuploidy (47, XXY), occurring in 1:600 males, and represents the most frequent cause of hypergonadotropic hypogonadism in men [7, 8]. The 80-85% of KS patients are characterized by a 47, XXY karyotype. Other anomalies in the number of sex chromosomes have also been reported, including the presence of a further supernumerary X chromosome 48, XXXY, a 48, XXYY karyotype or mosaicisms such as 46, XY/47, XXY. The fifty percent of the supernumerary X chromosomes is of maternal origin, while the role of maternal or paternal age at the time of conception is still unclear. Even if it has gone by more than 70 years since Dr. Harry Fitch Klinefelter described the first case, the relationship between clinical phenotypes and genetic background has not been fully understood; in general, phenotype correlates with the number of extra X chromosomes, with mosaicism patients exhibiting less severe signs and symptoms [9].
KS is characterized by an extreme heterogeneity in clinical presentation. In 1960s-1970s, KS has been reported to be prevalent among men institutionalized because of mental disability or guilty of sexual crimes. The studies above had been extensively criticized, although their results were partially confirmed in subsequent observations [10]. At the time of writing of the present review, no well-defined guideline on KS diagnosis has been published; this is a confirmation that, despite improvements in understanding, the rise of a clinical suspicion is still challenging.
Only a minority of KS subjects are diagnosed before puberty (about 10%). Most KS subjects show normal pubertal development: T secretion is still preserved, as well as testicular development; following this, development of testes arrests and, in rare cases, even its involution occurs [11]. In line with this, a condition of a relative hypogonadism can be found in the transitional phase, when endogenous T levels appear to be in the lower part of the normal range. In two out of three adults, overt hypogonadism is generally diagnosed. Besides sexual dysfunctions and the fertility aspect (non-obstructive azoospermia) that today seem to be overcome in a satisfactory manner by the means of testicular sperm extraction, KS subjects present a large number of metabolic alterations which may increase their morbidity and mortality [12-14]. These could be influenced by the already stated number of supernumerary X, but also by the duration of diseases, the advancing age and, according to some authors, the delay in TRT [9].
In order to ensure the normal sexual development and to prevent long-term complications of hypogonadism, a preventive T therapy in adolescents with KS has been proposed [15]. However, it should be emphasized that it is not supported by sufficient evidence, since there has been no controlled clinical trial so far. Moreover, studies analyzing the effects of T replacement therapy (TRT) among KS subjects were cross-sectional and in none of them T dosing was standardized. Only two studies showed a partial correction of the fat mass/body mass ratio following TRT, while an improvement in cognitive performance was not demonstrated [16]. A recent review of the literature showed that the benefits of T therapy among KS are still uncertain, especially in those with normal T and high levels of gonadotropins [17].
Nevertheless, highly specific clinical features and laboratory findings include small and firm testicles (<4 cc), hypergonadotropic hypogonadism, gynecomastia, language delay and infertility, which are present in most of the affected subjects. Since KS may also have a clinical phenotype indistinguishable from 46, XY males, the evaluation of the karyotype is requested in order to clinch the diagnosis in difficult cases [9].
4. Brain morphological and functional studies
Clinical studies confirmed that KS patients are characterized by smaller total brain, grey and white matter volume, compared to general population, suggesting that anatomical structures may be implicated in the impairment of cognitive, psychological, social and emotional domains [18-20]. In particular, KS patients displayed decreased grey and white matter volume in the insula, putamen, caudate nucleus, hippocampus, amygdala, right parahippocampal region, cerebellum, temporal lobe and frontal inferior orbita [18, 20-24]. On the other hand, KS patients are characterized by increased grey matter volume in right postcentral gyrus, precuneus, parietal, sensorimotor and occipital regions and enlarged lateral ventricles [18, 20, 21, 23-25]. Little information is available on the possible causes underlying the above-reported differences; nevertheless, the reduced grey matter volume of the amygdala, superior temporal cortex and insula and the increased grey matter volume in the parietal lobe of KS patients have been shown to be linked to sex chromosome number, whereas the increased grey matter volume in the motor cortex to the X chromosome number alone [26].
Grey matter volume reduction in the hippocampus, parahippocampal cortices and amygdala is associated with memory impairment and mood dysregulation [20, 23]; in particular, the involvement of amygdala may be related to atypical temperament, passivity and reduced sexual drive [20]. The decreased left inferior frontal area and the motor strip, particularly on the left side, were linked to the muscular weakness in the trunk and shoulders [21, 27]. On the contrary, the increased grey matter volume in the sensorimotor and occipital regions in KS was associated with sensorimotor deficits [20]. Ventricular volume was demonstrated to be inversely correlated with verbal processing speed and verbal executive function [24]. The literature on this topic is conflicting and other authors have found no significant association between changes in grey matter volume and cognitive and psychological factors in KS patients [18].
Few clinical studies concurrently evaluated brain structure and functionality in KS patients. Studies focusing on brain activity by single photon emission computed tomography (SPECT) and measuring regional cerebral blood flow (rCBF) demonstrated that in KS patients, rCBF was significantly increased in the right hemisphere regions, in particular in prefrontal motor, parietal associative and temporal language areas, when compared to controls; moreover, increased rCBF in several right-sided temporal gyri was associated with lower verbal scores [28]. Studies with functional magnetic resonance imaging (MRI) found that the activation of the amygdala and the insula, areas involved in socio-emotional function and in subjective emotional experience, respectively, were reduced in KS. Moreover, the activation of the fusiform gyrus and the superior temporal sulcus, which play a role in the perceptual processing of faces, was also reduced [29]. Lastly, in KS patients, a less lateralized language activity was demonstrated, due to increased activity in the right and reduced activity in the left hemisphere, particularly in the superior temporal gyrus and the supra-marginal gyrus regions. These functional changes were associated with impaired thinking and language skills [30].
Few clinical studies focused on the effect of TRT on the brain and neural pathways and brain volume in KS, with conflicting results as well. Studies comparing T-treated and untreated KS patients found no differences in total brain, grey and white matter volume [18, 24]. A study comparing prepuberal KS with controls confirmed that T levels did not influence grey and white matter volume [20]. In contrast with these results, a second study demonstrated that T-untreated KS patients had smaller temporal volume when compared to the general population, whereas no significant difference was found between T-treated KS patients and the general population [31].
In summary, the results of morphological and functional studies focusing on the brain demonstrated that KS patients are characterized by significant differences in brain structure, including reduced total brain, grey and white matter volume, when compared to general population; these differences have been associated with functional impairment, involving in particular language abnormalities, but further research is still warranted.
5. The XY theory for psychosis: the role of x chromosome
It is well known that the X chromosome carries genes responsible for the neural development as well as cognitive and mental functioning [22]. In general, a greater vulnerability to psychopathology has been reported among KS [32-38]. Considering the schizophrenia spectrum disorders, KS has been found to show higher scores in all domains regarding schizotypal and schizophrenia symptoms [34]. Furthermore, studies using cytogenetic analysis on patients suffering from schizophrenia and other psychotic disorders found a higher prevalence of 47,XXX and 47,XXY karyotypes when compared to general population [32, 33, 36, 39-42].
Among KS, psychiatric symptoms encompass different manifestations, according to a broad spectrum of phenotypes [8]. In particular, an increasing incidence of conduct disorders, anxiety and depression, deficits in attention and impulse control was found [43-45]. A higher risk for autism and attention deficit hyperactivity disorder (ADHD) traits were reported [32-38].
Psychobiological traits (endophenotypes) associated with psychosis have also been described. In psychosis, the most frequent endophenotypes are eye tracking dysfunction, including smooth pursuit eye movement (SPEM) and sensory gating which are both genetically determined. Sensory gating is commonly evaluated through prepulse inhibition (PPI) and P50 suppression. Van Rijn et al., demonstrated significant impairment in SPEM and PPI in KS patients when compared to controls, while no differences were found in P50 [42, 46-56].
From an intelligence quotient (IQ) perspective, even if KS shows normal IQ scores, two specific cognitive patterns can be described: one is characterized by verbal IQ (VIQ) score lower than performance IQ (PIQ) (VIQ < PIQ), the other by PIQ lower than VIQ (PIQ < VIQ) [57, 58]. The former shows the significantly higher level of autism traits; the latter presents higher schizotypal traits, in particular, magical thinking, delusional ideation and eccentric behavior. These associations are independent of age [59-61].
A reduction of the mesial temporal lobe bilaterally has been proposed as the biological mechanism leading to vulnerability to psychosis [62-64]. This is in line with findings among patients at risk or suffering from schizophrenia as confirmed in MRI studies [65-70].
6. Psychiatric disorders and psychopa- thology associated with Klinefelter syndrome
As already stated, a large number of studies reported an increased risk not only for psychotic disorders but also for depression and anxiety in KS [19, 36, 41, 44, 71, 72].
A survey conducted in Denmark among 832 KS patients and 4033 controls showed an increased risk of hospitalization for psychiatric disorders (HR 3.65) [32]. Other studies reported a high prevalence of depression ranging from 19 to 24% [36, 41]. It has been questioned whether depressive symptoms are specifically associated with genotype alterations in KS or are consequences of physical and emotional traits due to the syndrome [73]. Van Rijn et al. reported an increasing emotional arousal and difficulty in the identification and verbalization of emotions [34]. The organic basis for this could be probably found in alterations in the amygdala and other limbic structures involved in the regulation of emotions, as well as in aggressive and impulsive behaviors [74-77]. A role for genetic and hormones in the early stages of development has been hypothesized, as confirmed by the finding of estrogen and androgen receptors in mammalian hippocampus and amygdala and in the temporal area in human [78-81]. Another proposed factor is the cortisol level, increasing during anxiety and depression states [82, 83]. A relationship between hypogonadism and depression has also been proposed. Two population-based studies showed a hazard ratio of 4.2 for depression being hypogonadal and of 1.55–2.71 for hypogonadism being depressed [84, 85]. Indeed, evidences on this topic are conflicting: some studies reported an improvement in depression in KS undergoing TRT, while others did not [86-88]. However, the link between hypogonadism and depression might be considered in the light of the shared symptoms.
For what concerns anxiety, a study of Tartaglia et al. screened behavioral features of 57 KS: 25% reported pathological effects or had increased risk scores in the areas of anxiety, depression and somatic complaints; 50% were in the area of social withdrawal [89]. These results were confirmed by Bruining et al. in a study on 50 KS: depressive disorder was reported in 24% and anxiety disorders in 32% [36]. Anxiety and depression are the bases for difficult social interactions; in particular, they show social anxiety and withdrawal, problems in peer-relationships, social impulsivity and shyness [30, 58, 71, 90-94].
Psychopathological traits in KS should be considered in the light of cognitive dysfunctions related with chromosome trisomies, such as difficulties in speech and language, motor skills, educational achievement and, hence, in basic psychophysiological mechanisms in the area of visuo-motor control and sensory gating [95].
A significant clinical variability in cognitive functioning and school performance has also been found in KS [57, 96, 97]. When compared with other chromosomal trisomies (trisomy 21, trisomy 18), KS on average does not suffer from global intellectual disability [97]. However, many studies associated KS with mild cognitive impairment; specifically, subjects with XXY-karyotype are reported to be more dysfunctional in the language area, while XXX have mild global intellectual delay [96, 98, 99]. Indeed, according to some epidemiological studies, groups of subjects with mild learning disorders, also have higher rates of psychiatric disorders [100, 101].
Conclusion
Given that X chromosome has numerous genes co-regulating neural development, cognitive and mental functioning and given that KS is an aneuploidy characterized by at least an extra X chromosome, it can be considered a human “experiment of nature” to verify the role of those genes in psychosis disorders. Several psychiatric symptoms have been associated with KS according to a broad spectrum of phenotypes. Schizophrenia, autism, attention deficit hyperactivity disorder, depression, anxiety and conduct disorders were those more frequently reported in different surveys.
Although it is generally accepted that the basis of vulnerability to psychosis is a reduction of mesial temporal lobe bilaterally, especially the reduction of gray matter in that area, MRI studies carried out in subjects with KS have been inconclusive so far. Similarly, TRT, even in those KS subjects with a deficit of T, was unsuccessful in enhancing the psychotic disorders.
In conclusion, the risk of psychosis, depression and anxiety is increased in subjects with KS. Additional studies are needed to better define the relationship between aneuploidy, T deficit and the risk of psychiatric and cognitive disorders in subjects with KS.
Acknowledgements
This study was performed on behalf of the Klinefelter ItaliaN Group (KING). Coordinators: Giancarlo Balercia (Ancona), Marco Bonomi (Milan), Aldo Calogero (Catania), Giovanni Corona (Bologna), Francesco Giorgino (Bari), Andrea Fabbri (Rome), Alberto Ferlin (Padua), Emanuele Ferrante (Milan), Felice Francavilla (L’Aquila), Vito Angelo Giagulli (Conversano, Bari), Emmanuele Jannini (Rome), Fabio Lanfranco (Turin), Mario Maggi (Florence), Daniela Pasquali (Naples), Rosario Pivonello (Naples), Alessandro Pizzocaro (Milan), Antonio Radicioni (Rome), Vincenzo Rochira (Modena), Linda Vignozzi (Florence).
LIST OF ABBREVIATIONS
- AR
Androgen Receptor
- rCBF
Regional Cerebral Blood Flow
- KS
Klinefelter Syndrome
- IQ
Intelligence Quotient
- MRI
Magnetic Resonance Imaging
- PIQ
Performance Intelligence Quotient
- PPI
Prepulse Inhibition
- SPEM
Smooth Pursuit Eye Movement
- T
Testosterone
- TRT
Testosterone Replacement Therapy
- VIQ
Verbal Intelligence Quotient
Consent for Publication
Not applicable.
Conflict of Interest
The authors declare no conflict of interest, financial or otherwise.
REFERENCES
- 1.Crow T.J. The XY gene hypothesis of psychosis: Origins and current status. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2013;162B(8):800–824. doi: 10.1002/ajmg.b.32202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Bao A.M., Swaab D.F. Sex differences in the brain, behavior, and neuropsychiatric disorders. Neuroscientist. 2010;16(5):550–565. doi: 10.1177/1073858410377005. [DOI] [PubMed] [Google Scholar]
- 3.Barrick T.R., Mackay C.E., Prima S., Maes F., Vandermeulen D., Crow T.J., Roberts N. Automatic analysis of cerebral asymmetry: An exploratory study of the relationship between brain torque and planum temporale asymmetry. Neuroimage. 2005;24(3):678–691. doi: 10.1016/j.neuroimage.2004.09.003. [DOI] [PubMed] [Google Scholar]
- 4.Zitzmann M., Depenbusch M., Gromoll J., Nieschlag E. X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. J. Clin. Endocrinol. Metab. 2004;89(12):6208–6217. doi: 10.1210/jc.2004-1424. [DOI] [PubMed] [Google Scholar]
- 5.Wikström A.M., Painter J.N., Raivio T., Aittomäki K., Dunkel L. Genetic features of the X chromosome affect pubertal development and testicular degeneration in adolescent boys with Klinefelter syndrome. Clin. Endocrinol. (Oxf.) 2006;65(1):92–97. doi: 10.1111/j.1365-2265.2006.02554.x. [DOI] [PubMed] [Google Scholar]
- 6.Giagulli V.A., Guastamacchia E., Licchelli B., Triggiani V. Serum testosterone and cognitive function in ageing male: Updating the evidence. Recent Pat. Endocr. Metab. Immune Drug Discov. 2016;10(1):22–30. doi: 10.2174/1872214810999160603213743. [DOI] [PubMed] [Google Scholar]
- 7.Bojesen A., Juul S., Gravholt C.H. Prenatal and postnatal prevalence of Klinefelter syndrome: A national registry study. J. Clin. Endocrinol. Metab. 2003;88(2):622–626. doi: 10.1210/jc.2002-021491. [DOI] [PubMed] [Google Scholar]
- 8.Lanfranco F., Kamischke A., Zitzmann M., Nieschlag E. Klinefelter’s syndrome. Lancet. 2004;364(9430):273–283. doi: 10.1016/S0140-6736(04)16678-6. [DOI] [PubMed] [Google Scholar]
- 9.Bonomi M., Rochira V., Pasquali D., Balercia G., Jannini E.A., Ferlin A., Klinefelter Italia N. Group (KING). Klinefelter syndrome (KS): Genetics, clinical phenotype and hypogonadism. J. Endocrinol. Invest. 2017;40(2):123–134. doi: 10.1007/s40618-016-0541-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Stochholm K., Bojesen A., Jensen A.S., Juul S., Gravholt C.H. Criminality in men with Klinefelter’s syndrome and XYY syndrome: A cohort study. BMJ Open. 2012;2(1):e000650. doi: 10.1136/bmjopen-2011-000650. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bastida M.G., Rey R.A., Bergadá I., Bedecarrás P., Andreone L., del Rey G., Boywitt A., Ropelato M.G., Cassinelli H., Arcari A., Campo S., Gottlieb S. Establishment of testicular endocrine function impairment during childhood and puberty in boys with Klinefelter syndrome. Clin. Endocrinol. (Oxf.) 2007;67(6):863–870. doi: 10.1111/j.1365-2265.2007.02977.x. [DOI] [PubMed] [Google Scholar]
- 12.Corona G., Petrone L., Paggi F., Lotti F., Boddi V., Fisher A., Vignozzi L., Balercia G., Sforza A., Forti G., Mannucci E., Maggi M. Sexual dysfunction in subjects with Klinefelter’s syndrome. Int. J. Androl. 2010;33(4):574–580. doi: 10.1111/j.1365-2605.2009.00986.x. [DOI] [PubMed] [Google Scholar]
- 13.Corona G., Pizzocaro A., Lanfranco F., Garolla A., Pelliccione F., Vignozzi L., Ferlin A., Foresta C., Jannini E.A., Maggi M., Lenzi A., Pasquali D., Francavilla S., Klinefelter Italia N. Group (KING). Sperm recovery and ICSI outcomes in Klinefelter syndrome: A systematic review and meta-analysis. Hum. Reprod. Update. 2017;23(3):265–275. doi: 10.1093/humupd/dmx008. [DOI] [PubMed] [Google Scholar]
- 14.Calogero A.E., Giagulli V.A., Mongioì L.M., Triggiani V., Radicioni A.F., Jannini E.A., Pasquali D., Klinefelter Italia N. Group (KING). Klinefelter syndrome: Cardiovascular abnormalities and metabolic disorders. J. Endocrinol. Invest. 2017;40(7):705–712. doi: 10.1007/s40618-017-0619-9. [DOI] [PubMed] [Google Scholar]
- 15.Mehta A., Paduch D.A. Klinefelter syndrome: An argument for early aggressive hormonal and fertility management. Fertil. Steril. 2012;98(2):274–283. doi: 10.1016/j.fertnstert.2012.06.001. [DOI] [PubMed] [Google Scholar]
- 16.Ross J.L., Roeltgen D.P., Stefanatos G., Benecke R., Zeger M.P., Kushner H., Ramos P., Elder F.F., Zinn A.R. Cognitive and motor development during childhood in boys with Klinefelter syndrome. Am. J. Med. Genet. A. 2008;146A(6):708–719. doi: 10.1002/ajmg.a.32232. [DOI] [PubMed] [Google Scholar]
- 17.Gies I., Unuane D., Velkeniers B., De Schepper J. Management of Klinefelter syndrome during transition. Eur. J. Endocrinol. 2014;171(2):R67–R77. doi: 10.1530/EJE-14-0213. [DOI] [PubMed] [Google Scholar]
- 18.Skakkebæk A., Gravholt C.H., Rasmussen P.M., Bojesen A., Jensen J.S., Fedder J., Laurberg P., Hertz J.M., Ostergaard J.R., Pedersen A.D., Wallentin M. Neuroanatomical correlates of Klinefelter syndrome studied in relation to the neuropsychological profile. Neuroimage Clin. 2013;4:1–9. doi: 10.1016/j.nicl.2013.10.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.DeLisi L.E., Maurizio A.M., Svetina C., Ardekani B., Szulc K., Nierenberg J., Leonard J., Harvey P.D. Klinefelter’s syndrome (XXY) as a genetic model for psychotic disorders. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2005;135B(1):15–23. doi: 10.1002/ajmg.b.30163. [DOI] [PubMed] [Google Scholar]
- 20.Bryant D.M., Hoeft F., Lai S., Lackey J., Roeltgen D., Ross J., Reiss A.L. Neuroanatomical phenotype of Klinefelter syndrome in childhood: A voxel-based morphometry study. J. Neurosci. 2011;31(18):6654–6660. doi: 10.1523/JNEUROSCI.5899-10.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Giedd J.N., Clasen L.S., Wallace G.L., Lenroot R.K., Lerch J.P., Wells E.M., Blumenthal J.D., Nelson J.E., Tossell J.W., Stayer C., Evans A.C., Samango-Sprouse C.A. XXY (Klinefelter syndrome): A pediatric quantitative brain magnetic resonance imaging case-control study. Pediatrics. 2007;119(1):e232–e240. doi: 10.1542/peds.2005-2969. [DOI] [PubMed] [Google Scholar]
- 22.Patwardhan A.J., Brown W.E., Bender B.G., Linden M.G., Eliez S., Reiss A.L. Reduced size of the amygdala in individuals with 47,XXY and 47,XXX karyotypes. Am. J. Med. Genet. 2002;114(1):93–98. doi: 10.1002/ajmg.10154. [DOI] [PubMed] [Google Scholar]
- 23.Shen D., Liu D., Liu H., Clasen L., Giedd J., Davatzikos C. Automated morphometric study of brain variation in XXY males. Neuroimage. 2004;23(2):648–653. doi: 10.1016/j.neuroimage.2004.08.018. [DOI] [PubMed] [Google Scholar]
- 24.Itti E., Gaw Gonzalo I.T., Pawlikowska-Haddal A., Boone K.B., Mlikotic A., Itti L., Mishkin F.S., Swerdloff R.S. The structural brain correlates of cognitive deficits in adults with Klinefelter’s syndrome. J. Clin. Endocrinol. Metab. 2006;91(4):1423–1427. doi: 10.1210/jc.2005-1596. [DOI] [PubMed] [Google Scholar]
- 25.Warwick M.M., Doody G.A., Lawrie S.M., Kestelman J.N., Best J.J., Johnstone E.C. Volumetric magnetic resonance imaging study of the brain in subjects with sex chromosome aneuploidies. J. Neurol. Neurosurg. Psychiatry. 1999;66(5):628–632. doi: 10.1136/jnnp.66.5.628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kasahara M. Abstracts of 17th Annual Meeting of the Organization for Human Brain Mapping; Quebec City, Canada. 2011. [Google Scholar]
- 27.Parent A. 1996. [Google Scholar]
- 28.Itti E., Gaw Gonzalo I.T., Boone K.B., Geschwind D.H., Berman N., Pawlikowska-Haddal A., Itti L., Mishkin F.S., Swerdloff R.S. Functional neuroimaging provides evidence of anomalous cerebral laterality in adults with Klinefelter’s syndrome. Ann. Neurol. 2003;54(5):669–673. doi: 10.1002/ana.10735. [DOI] [PubMed] [Google Scholar]
- 29.van Rijn S., Swaab H., Baas D., de Haan E., Kahn R.S., Aleman A. Neural systems for social cognition in Klinefelter syndrome (47,XXY): Evidence from fMRI. Soc. Cogn. Affect. Neurosci. 2012;7(6):689–697. doi: 10.1093/scan/nsr041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.van Rijn S., Aleman A., Swaab H., Vink M., Sommer I., Kahn R.S. Effects of an extra X chromosome on language lateralization: An fMRI study with Klinefelter men(47,XXY). Schizophr. Res. 2008;101(1-3):17–25. doi: 10.1016/j.schres.2008.02.001. [DOI] [PubMed] [Google Scholar]
- 31.Patwardhan A.J., Eliez S., Bender B., Linden M.G., Reiss A.L. Brain morphology in Klinefelter syndrome: Extra X chromosome and testosterone supplementation. Neurology. 2000;54(12):2218–2223. doi: 10.1212/wnl.54.12.2218. [DOI] [PubMed] [Google Scholar]
- 32.Bojesen A., Juul S., Birkebaek N.H., Gravholt C.H. Morbidity in Klinefelter syndrome: A Danish register study based on hospital discharge diagnoses. J. Clin. Endocrinol. Metab. 2006;91(4):1254–1260. doi: 10.1210/jc.2005-0697. [DOI] [PubMed] [Google Scholar]
- 33.DeLisi L.E., Friedrich U., Wahlstrom J., Boccio-Smith A., Forsman A., Eklund K., Crow T.J. Schizophrenia and sex chromosome anomalies. Schizophr. Bull. 1994;20(3):495–505. doi: 10.1093/schbul/20.3.495. [DOI] [PubMed] [Google Scholar]
- 34.van Rijn S.; Aleman, A.; Swaab, H.; Kahn, R. Klinefelter’s syndrome (karyotype 47,XXY) and schizophrenia-spectrum pathology. Br. J. Psychiatry. 2006;189:459–460. doi: 10.1192/bjp.bp.105.008961. [DOI] [PubMed] [Google Scholar]
- 35.van Rijn S., Swaab H., Aleman A., Kahn R.S. Social behavior and autism traits in a sex chromosomal disorder: Klinefelter (47XXY) syndrome. J. Autism Dev. Disord. 2008;38(9):1634–1641. doi: 10.1007/s10803-008-0542-1. [DOI] [PubMed] [Google Scholar]
- 36.Bruining H., Swaab H., Kas M., van Engeland H. Psychiatric characteristics in a self-selected sample of boys with Klinefelter syndrome. Pediatrics. 2009;123(5):e865–e870. doi: 10.1542/peds.2008-1954. [DOI] [PubMed] [Google Scholar]
- 37.Kumra S., Wiggs E., Krasnewich D., Meck J., Smith A.C., Bedwell J., Fernandez T., Jacobsen L.K., Lenane M., Rapoport J.L. Brief report: Association of sex chromosome anomalies with childhood-onset psychotic disorders. J. Am. Acad. Child Adolesc. Psychiatry. 1998;37(3):292–296. doi: 10.1097/00004583-199803000-00014. [DOI] [PubMed] [Google Scholar]
- 38.Bishop D.V., Jacobs P.A., Lachlan K., Wellesley D., Barnicoat A., Boyd P.A., Fryer A., Middlemiss P., Smithson S., Metcalfe K., Shears D., Leggett V., Nation K., Scerif G. Autism, language and communication in children with sex chromosome trisomies. Arch. Dis. Child. 2011;96(10):954–959. doi: 10.1136/adc.2009.179747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Nielsen J., Wohlert M. Chromosome abnormalities found among 34,910 newborn children: Results from a 13-year incidence study in Arhus, Denmark. Hum. Genet. 1991;87(1):81–83. doi: 10.1007/BF01213097. [DOI] [PubMed] [Google Scholar]
- 40.Kumra S., Jacobsen L.K., Lenane M., Zahn T.P., Wiggs E., Alaghband-Rad J., Castellanos F.X., Frazier J.A., McKenna K., Gordon C.T., Smith A., Hamburger S., Rapoport J.L. “Multidimensionally impaired disorder”: Is it a variant of very early-onset schizophrenia? J. Am. Acad. Child Adolesc. Psychiatry. 1998;37(1):91–99. doi: 10.1097/00004583-199801000-00022. [DOI] [PubMed] [Google Scholar]
- 41.Boks M.P., de Vette M.H., Sommer I.E., van Rijn S., Giltay J.C., Swaab H., Kahn R.S. Psychiatric morbidity and X-chromosomal origin in a Klinefelter sample. Schizophr. Res. 2007;93(1-3):399–402. doi: 10.1016/j.schres.2007.03.015. [DOI] [PubMed] [Google Scholar]
- 42.Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: Etymology and strategic intentions. Am. J. Psychiatry. 2003;160(4):636–645. doi: 10.1176/appi.ajp.160.4.636. [DOI] [PubMed] [Google Scholar]
- 43.Mandoki M.W., Sumner G.S., Hoffman R.P., Riconda D.L. A review of Klinefelter’s syndrome in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry. 1991;30(2):167–172. doi: 10.1097/00004583-199103000-00001. [DOI] [PubMed] [Google Scholar]
- 44.Bender B.G., Harmon R.J., Linden M.G., Robinson A. Psychosocial adaptation of 39 adolescents with sex chromosome abnormalities. Pediatrics. 1995;96(2 Pt 1):302–308. [PubMed] [Google Scholar]
- 45.Walzer S., Wolff P.H., Bowen D., Silbert A.R., Bashir A.S., Gerald P.S., Richmond J.B. A method for the longitudinal study of behavioral development in infants and children: The early development of XXY children. J. Child Psychol. Psychiatry. 1978;19(3):213–229. doi: 10.1111/j.1469-7610.1978.tb00465.x. [DOI] [PubMed] [Google Scholar]
- 46.Cannon T.D. The inheritance of intermediate phenotypes for schizophrenia. Curr. Opin. Psychiatry. 2005;18(2):135–140. doi: 10.1097/00001504-200503000-00005. [DOI] [PubMed] [Google Scholar]
- 47.O’Driscoll G.A., Callahan B.L. Smooth pursuit in schizophrenia: A meta-analytic review of research since 1993. Brain Cogn. 2008;68(3):359–370. doi: 10.1016/j.bandc.2008.08.023. [DOI] [PubMed] [Google Scholar]
- 48.Levy D.L., Holzman P.S., Matthysse S., Mendell N.R. Eye tracking dysfunction and schizophrenia: A critical perspective. Schizophr. Bull. 1993;19(3):461–536. doi: 10.1093/schbul/19.3.461. [DOI] [PubMed] [Google Scholar]
- 49.Calkins M.E., Iacono W.G. Eye movement dysfunction in schizophrenia: A heritable characteristic for enhancing phenotype definition. Am. J. Med. Genet. 2000;97(1):72–76. doi: 10.1002/(sici)1096-8628(200021)97:1<72::aid-ajmg10>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
- 50.Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., Flach K., Nagamoto H., Bickford P., Leonard S., Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr. Bull. 1998;24(2):189–202. doi: 10.1093/oxfordjournals.schbul.a033320. [DOI] [PubMed] [Google Scholar]
- 51.Aukes M.F., Alizadeh B.Z., Sitskoorn M.M., Selten J.P., Sinke R.J., Kemner C., Ophoff R.A., Kahn R.S. Finding suitable phenotypes for genetic studies of schizophrenia: Hheritability and segregation analysis. Biol. Psychiatry. 2008;64(2):128–136. doi: 10.1016/j.biopsych.2007.12.013. [DOI] [PubMed] [Google Scholar]
- 52.Cadenhead K.S., Swerdlow N.R., Braff D.L. Relative risk of prepulse inhibition deficits in schizophrenia patients and their siblings. Biol. Psychiatry. 2001;49(8):126S–126S. [Google Scholar]
- 53.Ettinger U., Kumari V., Crawford T.J., Corr P.J., Das M., Zachariah E., Hughes C., Sumich A.L., Rabe-Hesketh S., Sharma T. Smooth pursuit and antisaccade eye movements in siblings discordant for schizophrenia. J. Psychiatr. Res. 2004;38(2):177–184. doi: 10.1016/s0022-3956(03)00105-5. [DOI] [PubMed] [Google Scholar]
- 54.Karoumi B., Saoud M., d’Amato T., Rosenfeld F., Denise P., Gutknecht C., Gaveau V., Beaulieu F.E., Daléry J., Rochet T. Poor performance in smooth pursuit and antisaccadic eye-movement tasks in healthy siblings of patients with schizophrenia. Psychiatry Res. 2001;101(3):209–219. doi: 10.1016/s0165-1781(01)00227-x. [DOI] [PubMed] [Google Scholar]
- 55.Wynn J.K., Dawson M.E., Schell A.M., McGee M., Salveson D., Green M.F. Prepulse facilitation and prepulse inhibition in schizophrenia patients and their unaffected siblings. Biol. Psychiatry. 2004;55(5):518–523. doi: 10.1016/j.biopsych.2003.10.018. [DOI] [PubMed] [Google Scholar]
- 56.Oranje B., Geyer M.A., Bocker K.B., Leon Kenemans J., Verbaten M.N. Prepulse inhibition and P50 suppression: Commonalities and dissociations. Psychiatry Res. 2006;143(2-3):147–158. doi: 10.1016/j.psychres.2005.11.002. [DOI] [PubMed] [Google Scholar]
- 57.Boada R., Janusz J., Hutaff-Lee C., Tartaglia N. The cognitive phenotype in Klinefelter syndrome: A review of the literature including genetic and hormonal factors. Dev. Disabil. Res. Rev. 2009;15(4):284–294. doi: 10.1002/ddrr.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Boone K.B., Swerdloff R.S., Miller B.L., Geschwind D.H., Razani J., Lee A., Gonzalo I.G., Haddal A., Rankin K., Lu P., Paul L. Neuropsychological profiles of adults with Klinefelter syndrome. J. Int. Neuropsychol. Soc. 2001;7(4):446–456. doi: 10.1017/s1355617701744013. [DOI] [PubMed] [Google Scholar]
- 59.van Rijn S., Swaab H. Vulnerability for psychopathology in Klinefelter syndrome: Age-specific and cognitive-specific risk profiles. Acta Paediatr. 2011;100(6):908–916. doi: 10.1111/j.1651-2227.2011.02289.x. [DOI] [PubMed] [Google Scholar]
- 60.Amminger G.P., Schlögelhofer M., Lehner T., Looser Ott S., Friedrich M.H., Aschauer H.N. Premorbid performance IQ deficit in schizophrenia. Acta Psychiatr. Scand. 2000;102(6):414–422. doi: 10.1034/j.1600-0447.2000.102006414.x. [DOI] [PubMed] [Google Scholar]
- 61.Ott S.L., Spinelli S., Rock D., Roberts S., Amminger G.P., Erlenmeyer-Kimling L. The New York High-Risk Project: Social and general intelligence in children at risk for schizophrenia. Schizophr. Res. 1998;31(1):1–11. doi: 10.1016/s0920-9964(98)00010-3. [DOI] [PubMed] [Google Scholar]
- 62.Lawrie S.M., Abukmeil S.S. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br. J. Psychiatry. 1998;172:110–120. doi: 10.1192/bjp.172.2.110. [DOI] [PubMed] [Google Scholar]
- 63.McCarley R.W., Wible C.G., Frumin M., Hirayasu Y., Levitt J.J., Fischer I.A., Shenton M.E. MRI anatomy of schizophrenia. Biol. Psychiatry. 1999;45(9):1099–1119. doi: 10.1016/s0006-3223(99)00018-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Wright I.C., Rabe-Hesketh S., Woodruff P.W., David A.S., Murray R.M., Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry. 2000;157(1):16–25. doi: 10.1176/ajp.157.1.16. [DOI] [PubMed] [Google Scholar]
- 65.Bogerts B., Ashtari M., Degreef G., Alvir J.M., Bilder R.M., Lieberman J.A. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res. 1990;35(1):1–13. doi: 10.1016/0925-4927(90)90004-p. [DOI] [PubMed] [Google Scholar]
- 66.Breier A., Buchanan R.W., Elkashef A., Munson R.C., Kirkpatrick B., Gellad F. Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch. Gen. Psychiatry. 1992;49(12):921–926. doi: 10.1001/archpsyc.1992.01820120009003. [DOI] [PubMed] [Google Scholar]
- 67.Shenton M.E., Kikinis R., Jolesz F.A., Pollak S.D., LeMay M., Wible C.G., Hokama H., Martin J., Metcalf D., Coleman M., McCarley R.W. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N. Engl. J. Med. 1992;327(9):604–612. doi: 10.1056/NEJM199208273270905. [DOI] [PubMed] [Google Scholar]
- 68.Pearlson G.D., Barta P.E., Powers R.E., Menon R.R., Richards S.S., Aylward E.H., Federman E.B., Chase G.A., Petty R.G., Tien A.Y. Ziskind-Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biol. Psychiatry. 1997;41(1):1–14. doi: 10.1016/s0006-3223(96)00373-3. [DOI] [PubMed] [Google Scholar]
- 69.Bryant N.L., Buchanan R.W., Vladar K., Breier A., Rothman M. Gender differences in temporal lobe structures of patients with schizophrenia: A volumetric MRI study. Am. J. Psychiatry. 1999;156(4):603–609. doi: 10.1176/ajp.156.4.603. [DOI] [PubMed] [Google Scholar]
- 70.Sanderson T.L., Best J.J., Doody G.A., Owens D.G., Johnstone E.C. Neuroanatomy of comorbid schizophrenia and learning disability: A controlled study. Lancet. 1999;354(9193):1867–1871. doi: 10.1016/s0140-6736(99)01049-1. [DOI] [PubMed] [Google Scholar]
- 71.Ratcliffe S.G., Butler G.E., Jones M. Edinburgh study of growth and development of children with sex chromosome abnormalities. IV. Birth Defects Orig. Artic. Ser. 1990;26(4):1–44. [PubMed] [Google Scholar]
- 72.Bender B.G., Harmon R.J., Linden M.G., Bucher-Bartelson B., Robinson A. Psychosocial competence of unselected young adults with sex chromosome abnormalities. Am. J. Med. Genet. 1999;88(2):200–206. doi: 10.1002/(sici)1096-8628(19990416)88:2<200::aid-ajmg18>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- 73.Turriff A., Levy H.P., Biesecker B. Klinefelter syndrome. Prevalence and psychosocial correlates of depressive symptoms among adolescents and adults with Klinefelter syndrome. Genet. Med. 2011;13(11):966–972. doi: 10.1097/GIM.0b013e3182227576. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Miyagawa Y., Tsujimura A., Fujita K., Matsuoka Y., Takahashi T., Takao T., Takada S., Matsumiya K., Osaki Y., Takasawa M., Oku N., Hatazawa J., Kaneko S., Okuyama A. Differential brain processing of audiovisual sexual stimuli in men: Comparative positron emission tomography study of the initiation and maintenance of penile erection during sexual arousal. Neuroimage. 2007;36(3):830–842. doi: 10.1016/j.neuroimage.2007.03.055. [DOI] [PubMed] [Google Scholar]
- 75.Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., Raichle M.E. A functional anatomical study of unipolar depression. J. Neurosci. 1992;12(9):3628–3641. doi: 10.1523/JNEUROSCI.12-09-03628.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.LeDoux J.E. Emotion: Clues from the brain. Annu. Rev. Psychol. 1995;46:209–235. doi: 10.1146/annurev.ps.46.020195.001233. [DOI] [PubMed] [Google Scholar]
- 77.Amen D.G., Stubblefield M., Carmicheal B., Thisted R. Brain SPECT findings and aggressiveness. Ann. Clin. Psychiatry. 1996;8(3):129–137. doi: 10.3109/10401239609147750. [DOI] [PubMed] [Google Scholar]
- 78.Gould E., Woolley C.S., Frankfurt M., McEwen B.S. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J. Neurosci. 1990;10(4):1286–1291. doi: 10.1523/JNEUROSCI.10-04-01286.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Simerly R.B., Chang C., Muramatsu M., Swanson L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: An in situ hybridization study. J. Comp. Neurol. 1990;294(1):76–95. doi: 10.1002/cne.902940107. [DOI] [PubMed] [Google Scholar]
- 80.Yokosuka M., Okamura H., Hayashi S. Postnatal development and sex difference in neurons containing estrogen receptor-alpha immunoreactivity in the preoptic brain, the diencephalon, and the amygdala in the rat. J. Comp. Neurol. 1997;389(1):81–93. doi: 10.1002/(sici)1096-9861(19971208)389:1<81::aid-cne6>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
- 81.Sarrieau A., Mitchell J.B., Lal S., Olivier A., Quirion R., Meaney M.J. Androgen binding sites in human temporal cortex. Neuroendocrinology. 1990;51(6):713–716. doi: 10.1159/000125415. [DOI] [PubMed] [Google Scholar]
- 82.Axelson D.A., Doraiswamy P.M., McDonald W.M., Boyko O.B., Tupler L.A., Patterson L.J., Nemeroff C.B., Ellinwood E.H., Jr, Krishnan K.R. Hypercortisolemia and hippocampal changes in depression. Psychiatry Res. 1993;47(2):163–173. doi: 10.1016/0165-1781(93)90046-j. [DOI] [PubMed] [Google Scholar]
- 83.Drevets W.C. Prefrontal cortical-amygdalar metabolism in major depression. Ann. N. Y. Acad. Sci. 1999;877:614–637. doi: 10.1111/j.1749-6632.1999.tb09292.x. [DOI] [PubMed] [Google Scholar]
- 84.Shores M.M., Sloan K.L., Matsumoto A.M., Moceri V.M., Felker B., Kivlahan D.R. Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch. Gen. Psychiatry. 2004;61(2):162–167. doi: 10.1001/archpsyc.61.2.162. [DOI] [PubMed] [Google Scholar]
- 85.Almeida O.P., Yeap B.B., Hankey G.J., Jamrozik K., Flicker L. Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch. Gen. Psychiatry. 2008;65(3):283–289. doi: 10.1001/archgenpsychiatry.2007.33. [DOI] [PubMed] [Google Scholar]
- 86.Wang C., Swerdloff R.S., Iranmanesh A., Dobs A., Snyder P.J., Cunningham G., Matsumoto A.M., Weber T., Berman N., Testosterone Gel Study Group Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J. Clin. Endocrinol. Metab. 2000;85(8):2839–2853. doi: 10.1210/jcem.85.8.6747. [DOI] [PubMed] [Google Scholar]
- 87.Wang C., Cunningham G., Dobs A., Iranmanesh A., Matsumoto A.M., Snyder P.J., Weber T., Berman N., Hull L., Swerdloff R.S. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J. Clin. Endocrinol. Metab. 2004;89(5):2085–2098. doi: 10.1210/jc.2003-032006. [DOI] [PubMed] [Google Scholar]
- 88.Steidle C., Schwartz S., Jacoby K., Sebree T., Smith T., Bachand R. North American AA2500 T Gel Study Group. AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J. Clin. Endocrinol. Metab. 2003;88(6):2673–2681. doi: 10.1210/jc.2002-021058. [DOI] [PubMed] [Google Scholar]
- 89.Tartaglia N., Cordeiro L., Howell S., Wilson R., Janusz J. The spectrum of the behavioral phenotype in boys and adolescents 47,XXY (Klinefelter syndrome). Pediatr. Endocrinol. Rev. 2010;8(Suppl. 1):151–159. [PMC free article] [PubMed] [Google Scholar]
- 90.Ratcliffe S. Long-term outcome in children of sex chromosome abnormalities. Arch. Dis. Child. 1999;80(2):192–195. doi: 10.1136/adc.80.2.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Geschwind D.H., Dykens E. Neurobehavioral and Psychosocial Issues in Klinefelter Syndrome. Learn. Disabil. Res. Pract. 2014;19(3):166–173. [Google Scholar]
- 92.Visootsak J., Graham J.M., Jr Social function in multiple X and Y chromosome disorders: XXY, XYY, XXYY, XXXY. Dev. Disabil. Res. Rev. 2009;15(4):328–332. doi: 10.1002/ddrr.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Robinson A., Bender B.G., Linden M.G., Salbenblatt J.A. Sex chromosome aneuploidy: The denver prospective study. Birth Defects Orig. Artic. Ser. 1990;26(4):59–115. [PubMed] [Google Scholar]
- 94.Stewart D.A., Bailey J.D., Netley C.T., Rovet J., Park E., Cripps M., Curtis J.A. Growth and development of children with X and Y chromosome aneuploidy from infancy to pubertal age: The Toronto study. Birth Defects Orig. Artic. Ser. 1982;18(4):99–154. [PubMed] [Google Scholar]
- 95.Bak C.W., Byun J.S., Lee J.H., Park J.H., Lee K.A., Shim S.H. Clinical and social characteristics of Korean men with Klinefelter syndrome. Int. J. Urol. 2012;19(5):443–449. doi: 10.1111/j.1442-2042.2012.02964.x. [DOI] [PubMed] [Google Scholar]
- 96.Bender B.G., Linden M.G., Robinson A. Verbal and spatial processing efficiency in 32 children with sex chromosome abnormalities. Pediatr. Res. 1989;25(6):577–579. doi: 10.1203/00006450-198906000-00004. [DOI] [PubMed] [Google Scholar]
- 97.Bender B.G., Linden M.G., Robinson A. Neuropsychological impairment in 42 adolescents with sex chromosome abnormalities. Am. J. Med. Genet. 1993;48(3):169–173. doi: 10.1002/ajmg.1320480312. [DOI] [PubMed] [Google Scholar]
- 98.Graham J.M., Jr, Bashir A.S., Stark R.E., Silbert A., Walzer S. Oral and written language abilities of XXY boys: Implications for anticipatory guidance. Pediatrics. 1988;81(6):795–806. [PubMed] [Google Scholar]
- 99.Netley C., Rovet J. Verbal deficits in children with 47,XXY and 47,XXX karyotypes: A descriptive and experimental study. Brain Lang. 1982;17(1):58–72. doi: 10.1016/0093-934x(82)90005-0. [DOI] [PubMed] [Google Scholar]
- 100.Heaton-Ward A. Psychosis in mental handicap. The tenth blake marsh lecture delivered before the royal college of psychiatrists, February 2, 1976. Br. J. Psychiatry. 1977;130:525–533. doi: 10.1192/bjp.130.6.525. [DOI] [PubMed] [Google Scholar]
- 101.Doody G.A., Johnstone E.C., Sanderson T.L., Owens D.G., Muir W.J. ‘Pfropfschizophrenie’ revisited. Schizophrenia in people with mild learning disability. Br. J. Psychiatry. 1998;173:145–153. doi: 10.1192/bjp.173.2.145. [DOI] [PubMed] [Google Scholar]
